Patient Guide: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 45 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04861259
Status: ACTIVE_NOT_RECRUITING
Condition: Atypical Hemolytic Uremic Syndrome
Phase: PHASE3

Where You Can Participate

This study is available at 45 locations across the country.

Top locations include:
  • • Orange, California
  • • San Francisco, California
  • • Aurora, Colorado
  • • And 42 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) - Join Clinical Trial NCTNCT04861259

How to Join This Clinical Trial - NCTNCT04861259

Learn how to participate in this PHASE3 trial studying an investigational therapy for Atypical Hemolytic Uremic Syndrome. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Atypical Hemolytic Uremic Syndrome. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Atypical Hemolytic Uremic Syndrome
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04861259 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 45 locations. Find a study site near you:

Clinical Research Site

Orange, California 92868 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94143 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 20010 - United States

Status: Contact for availability

Clinical Research Site

St Louis, Missouri 63110 - United States

Status: Contact for availability

Clinical Research Site

Cincinnati, Ohio 45229 - United States

Status: Contact for availability

Clinical Research Site

Columbus, Ohio 43212 - United States

Status: Contact for availability

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: Contact for availability

Clinical Research Site

Leuven, 3000 - Belgium

Status: Contact for availability

Clinical Research Site

Belo Horizonte, Minas Gerais 30150-221 - Brazil

Status: Contact for availability

And 35 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Atypical Hemolytic Uremic Syndrome:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships